Praxis Precision Medicines (PRAX) Cash from Financing Activities (2019 - 2026)
Praxis Precision Medicines (PRAX) posted Cash from Financing Activities of $4.6 million for Q2 2026, down 99.25% on a QoQ basis from $609.4 million in Q1 2026, and down 84.03% year-over-year from $28.6 million in Q2 2025.
Powered by 
Analysis
Praxis Precision Medicines (PRAX) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Praxis Precision Medicines has reported Cash from Financing Activities for 8 years, with the latest figure at $4.6 million in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 84.03% year-over-year to $4.6 million in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 522.55% increase from a year earlier, with the FY2025 full-year figure at $702.2 million, up 36.52% from the prior year.
- Cash from Financing Activities was $4.6 million for Q2 2026 at Praxis Precision Medicines, down from $609.4 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $612.5 million in Q4 2025, with the low at $504000.0 in Q2 2022.
- Average Cash from Financing Activities over 5 years is $113.7 million, with a median of $18.1 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities slumped 99.49% in 2022, then jumped 13724.4% in 2023.
- Over 5 years, Cash from Financing Activities stood at $5.4 million in 2022, then decreased by 23.41% to $4.1 million in 2023, then surged by 2657.32% to $113.8 million in 2024, then soared by 438.4% to $612.5 million in 2025, then sank by 99.25% to $4.6 million in 2026.
- The last three Cash from Financing Activities figures came in at $4.6 million (Q2 2026), $609.4 million (Q1 2026), and $612.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.54 Bn | 198.55 Bn | 7.24 Bn | -1.48 Bn |
| 2 | Gilead Sciences | 186.84 Bn | 183.58 Bn | 6.22 Bn | 2.34 Bn |
| 3 | Vertex Pharmaceuticals | 129.39 Bn | 121.54 Bn | 2.84 Bn | -426.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.06 Bn | 3.93 Bn | -1.22 Bn |
| 5 | Moderna | 69.00 Bn | 63.87 Bn | 52.00 Mn | 14.00 Mn |
| 6 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.67 Bn | 29.37 Bn | 992.69 Mn | 36.24 Mn |
| 8 | Biogen | 32.37 Bn | 31.08 Bn | 1.96 Bn | 1.30 Bn |
| 9 | Roivant Sciences | 28.18 Bn | 28.87 Bn | 1.16 Mn | -181.51 Mn |
| 10 | Praxis Precision Medicines | 8.34 Bn | 7.58 Bn | - | 4.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.57 Mn |
| Mar 31, 2026 | 609.43 Mn |
| Dec 31, 2025 | 612.52 Mn |
| Sep 30, 2025 | 6.76 Mn |
| Jun 30, 2025 | 28.63 Mn |
| Mar 31, 2025 | 54.27 Mn |
| Dec 31, 2024 | 113.77 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 216.36 Mn |
| Mar 31, 2024 | 182.76 Mn |
| Dec 31, 2023 | 4.13 Mn |
| Jun 30, 2023 | 69.68 Mn |
| Mar 31, 2023 | 18.07 Mn |
| Dec 31, 2022 | 5.39 Mn |
| Sep 30, 2022 | 3.37 Mn |
| Jun 30, 2022 | 504,000.00 |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 7.71 Mn |
| Sep 30, 2021 | 212,000.00 |
| Jun 30, 2021 | 99.39 Mn |
API Access
Praxis Precision Medicines Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PRAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PRAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PRAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();